Khanna, D; Seibold, J R; Wells, A; Distler, O; Allanore, Y; Denton, C; Furst, D E (2010). Systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials, outcome measures, and future study design. Current Rheumatology Review, 6(2):138-144.
Full text not available from this repository.
Abstract
Pulmonary involvement including interstitial lung disease (ILD) is the leading cause of mortality in patients with systemic sclerosis (scleroderma; SSc). This article reviews the current evidence based medicine regarding available therapies for SSc-ILD ; discusses the lessons learned from recent SSc-ILD randomized controlled trials (RCTs); and proposes outcome measures and recommendations for design of future RCTs for SSc-ILD.
| Item Type: | Journal Article, refereed, further contribution |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Rheumatology Clinic and Institute of Physical Medicine |
| DDC: | 610 Medicine & health |
| Language: | English |
| Date: | 2010 |
| Deposited On: | 02 Feb 2011 16:35 |
| Last Modified: | 23 Nov 2012 13:51 |
| Publisher: | Bentham Science |
| ISSN: | 1573-3971 |
| Publisher DOI: | 10.2174/157339710791330768 |
| PubMed ID: | 20676227 |
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page
